baber/WOPTO huggingface dataset:
Patent DE-69634622-T2 (DE)
Inventor: MENEZES EDGAR V
IPC: B29D11/00
Filed: 1996-05-03
Granted: 2006-03-02
Abstract: Concentric lens designs are disclosed for astigmatic presbyopes which comprise at least one surface which has a circular central portion and a plurality of concentric annular rings with at least three separate optical powers corresponding to a prescription for a patient and corresponding to 1) a basic distance spherical prescription Rx, 2) a near add spherical prescription Rx, and 3) a spherical prescription corresponding to the full, or preferably a fraction of the, cylindrical prescription Rx. An astigmatic presbyopic prescription contains an astigmatic correction, normally in the nature of a cylindrical prescription which specifies both the cylindrical optical power and the orientation of the cylindrical axis. The cylindrical prescription is taken into account in the design of the lens, but not with a cylindrical optical surface. Instead, the present invention recognizes that the brain can effectively discriminate between separate competing images by accepting an in-focus image and rejecting an out-of-focus image. Accordingly, a portion of the lens is provided with a spherical surface corresponding to the cylindrical prescription, or more preferably a fraction of the full cylindrical prescription, and the brain is relied upon to discriminate and accept an in-focus image to compensate for the patient's astigmatism.
Patent DE-69636432-T2 (DE)
Inventor: SZCZEPANSKI L
IPC: G01N27/90
Filed: 1996-02-22
Granted: 2007-03-01
Abstract: A method for determining the suitability of workpieces for machining. A workpiece is probed with a non-contact type sensor to produce a voltage reading corresponding to the mass of the workpiece. The reading is compared to a tolerance voltage range based on the mass of a reference workpiece and from this comparison it is determined whether the workpiece is an uncut or cut workpiece and if it is appropriate to machine the workpiece.\!
Patent DE-69703477-T2 (DE)
Inventor: MC FARLANE GLEN
IPC: H01R24/84
Filed: 1997-04-30
Granted: 2001-05-23
Abstract: A connector unit 1 comprises a latching shell 3 having three peripheral resilient tongues 4 at substantially 120 DEG  from one another each bearing an outwardly projecting latch 5. A catching sleeve 28 also arranged in the connector unit 1 has three peripheral arms 30 at substantially 120 DEG  from one another each provided with an inner latch catching groove 31. The peripheral arms 30 of the catching sleeve 28 are located angularly between the resilient tongues 4 of the latching shell 3, whereby the latches 5 are circumferentially alternating with the latch catching grooves 31. <IMAGE>
Patent DE-69729956-T2 (DE)
Inventor: GAST JAY
IPC: A61P15/18
Filed: 1997-07-23
Granted: 2004-12-16
Abstract: This invention provides a method of contraception which comprises administering to a female of child bearing age for a combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol for 23-25 days beginning on day 1 of the menstrual cycle, and wherein the same dosage of the progestin and estrogen combination is administered in each of the 23-25 days.
Patent DE-69736890-T2 (DE)
Inventor: TANAKA HIROSHI
IPC: C07D209/14
Filed: 1997-03-03
Granted: 2007-09-06
Abstract: The present invention relates to a fused heterocyclic compound of the formula (I) <CHEM> wherein each symbol is as defined in the specification, an optical isomer thereof, a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing a compound of the formula (I), an optical isomer thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable additive, and a medicament containing a compound of the formula (I), an optical isomer thereof or a pharmaceutically acceptable salt thereof. The compound of the present invention is a useful antipsychotic agent effective not only for positive symptoms centering on hallucination and delusion characteristic of the acute stage of schizophrenia, but also negative symptoms of apathy, abulia and autism. The inventive compound is expected to make a highly safe antipsychotic agent associated with less side effects, such as extrapyramidal symptoms and endocrine disturbance, which are observed when a conventional antipsychotic agent having a D2 receptor blocking action is administered. Therefore, the inventive compound can be used as a therapeutic agent for the diseases such as schizophrenia.
Patent DE-69737592-T2 (DE)
Inventor: NAGASE HIROSHI
IPC: A61K31/541
Filed: 1997-11-21
Granted: 2008-01-03
Abstract: This invention provides an antipruritic comprising an opiate K receptor agonist as an effective component, and morphinian derivatives which are useful for the treatment of pruritus caused by various diseases.
Patent DE-69812657-T2 (DE)
Inventor: MCLAREN L
IPC: H04N7/26
Filed: 1998-10-27
Granted: 2003-12-24
Abstract: A system and method for scrolling in a picture which is larger than MPEG standard in length or width or both in a video system, such as an interactive television system. In the preferred embodiment, the interactive television system comprises a video delivery system for providing video content, and at least one subscriber television including a display screen, wherein the subscriber television is coupled to the video delivery system. The video delivery system provides the compressed picture. The compressed picture has a length and/or a width which is larger than MPEG standard or alternatively is larger than the desirable viewing size. The compressed picture is subdivided into slices and possibly groups of slices such that the image may be smoothly scrolled. The subscriber television receives the compressed picture and operates to scroll in the compressed picture as desired by the user. The scrolling operation preferably includes providing additional compressed picture slices for decoding in place of slices in a previously viewed image of a portion of the compressed picture. The subscriber television then decodes the resulting picture and displays a next portion of the scrolled picture.
Patent DE-69818574-T2 (DE)
Inventor: DUTTON AMANDA
IPC: C08L67/04
Filed: 1998-07-18
Granted: 2004-07-29
Abstract: Products intended for use as hand mouldable materials should meet the objectives of not causing pain to the user when held in the hand, and retaining malleability for a sufficient but not excessive length of time. The invention hand-mouldable compositions comprise selected copolymers of lactones and lactides which manifest a melt temperature Tm in the range of from 48 to 58 DEG C and a crystallisation temperature Tc in the range of from 16 to 30 DEG C. They are preferably produced from  epsilon caprolactone and L-lactide, most desirably in a weight ratio of from 94:6 to 91:9, and especially at a reaction temperature in the range of from 150 to 190 DEG C. They are often coloured and can be employed in kits.
Patent DE-69820301-T2 (DE)
Inventor: ANZALONE SERGIO
IPC: A61K/
Filed: 1998-12-16
Granted: 2004-10-14
Abstract: A new crystalline form of 1-methyl-5-p-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester, a process for its preparation and pharmaceutical compositions endowed of anti-inflammatory, analgesic and antipyretic activity containing same are disclosed.
Patent DE-69825562-T2 (DE)
Inventor: FASKHOODY BEHROOZ
IPC: B65B51/30
Filed: 1998-05-22
Granted: 2005-09-29
Abstract: A forming and sealing unit (1) for producing aseptic sealed packages from a tube (2) of packaging material filled with a pourable food product, the unit having a fixed structure (3); a pair of forming assemblies (5, 5') interacting alternately and cyclically with the tube (2) of packaging material, and in turn having respective slides (6) movable vertically and in reciprocating manner with respect to the fixed structure (3), and respective pairs of jaws (7) having sealing means and movable between an open position and a closed position in which the sealing means cooperate with the tube (2) of packaging material; a first pair of control rods (15) for controlling the movement of the slides (6); and a second pair of control rods (16) for controlling the opening and closing movement of the jaws (7); the control rods (15, 16) being activated independently by respective servomotors (20, 21, 20', 21') controlled by a programmable control unit (60). <IMAGE>
Patent DE-69831429-T2 (DE)
Inventor: TUFFET SOPHIE
IPC: C12N15/09
Filed: 1998-05-06
Granted: 2006-06-29
Abstract: A process for the long-term preservation of DNA molecules and a packaging for practicing the same provides for extraction, purification and dehumidification of the DNA by any suitable technique carrying out an encapsulation in a sealed corrosion-proof metallic capsule of the DNA molecule.
Patent DE-69836587-T2 (DE)
Inventor: GERDES JOHN C
IPC: C12Q1/6834
Filed: 1998-04-16
Granted: 2007-10-11
Abstract: This invention is directed to a process for irreversibly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrixes exhibiting sufficient hydrophilicity and electropositivity to irreversibly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume:low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The invention, solid phase irreversibly bound nucleic acid, may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.
Patent DE-69836758-T2 (DE)
Inventor: MAERTENS GEERT
IPC: C12N7/00
Filed: 1998-11-06
Granted: 2007-10-11
Abstract: The finding that the human proteins annexin V, tubulin and apolipoprotein B bind to the hepatitis C virus envelope proteins E1 and/or E2 and the usage of these human proteins to diagnose and treat an infection with hepatitis C virus are described. The usage of the latter proteins to enrich HCV envelope proteins and molecules which inhibit binding of HCV to these human proteins, as well as vaccines employing the E1 and/or E2 binding domains are also disclosed.
Patent DE-69918213-T2 (DE)
Inventor: CARLSSON NICLAS
IPC: B01D46/52
Filed: 1999-04-06
Granted: 2005-06-30
Abstract: Method at the fabrication of filters with deep folds for the connecting of opposed sides of the filter folds with each other to prevent blow up and ensure intended shape, comprising the welding of an intermediate distance element sheet (16) to the filter material (17) on each sides. The distance element sheet includes bridges and or connections between parts welded to the different filter sides, the bridges being extendable, for instance curved or angled parts. In particular these bridges may be extendable to different lengths at different locations in the filter in order to achieve for instance a triangular cross section. <IMAGE>
Patent DE-69918811-T2 (DE)
Inventor: CHISHOLM STEPHEN
IPC: C09D4/02
Filed: 1999-03-11
Granted: 2005-07-21
Abstract: A method of preparing a branched polymer comprising the steps of mixing together a monofunctional vinylic monomer with from 0.3-100 % w/w of a polyfunctional vinylic monomer and from 0.0001-50% w/w of a chain transfer agent and thereafter reacting said mixture to form a polymer. The resulting soluble branched polymers are useful as components of surface coatings and inks or as moulding resins.
Patent DE-69927056-T2 (DE)
Inventor: LEWANDOWSKI TROY R
IPC: C03B29/08
Filed: 1999-11-17
Granted: 2006-01-19
Abstract: A forced convection furnace (20) and method for heating glass sheets includes a forced convection heater (42) having lower hot gas distributors (44) located below alternate conveyor rolls (38) to provide upward gas flow both upstream and downstream thereof along a direction of conveyance to provide heating from below of the glass sheets being conveyed within a heating chamber (32) of a housing (22) of the furnace. The forced convection heater (42) also includes upper hot gas distributors (52) for providing heating from above of the glass sheets being conveyed within the heating chamber (32).
Patent DE-69928660-T2 (DE)
Inventor: BIEDERMANN ELFI
IPC: A61K9/127
Filed: 1999-04-21
Granted: 2006-09-14
Abstract: Vitamin PP compounds and compounds with anti-pellagra activity such as nicotinic acid and nicotinamide are useful for the reduction, elimination, and prevention of side-effects of immunosuppressive and anti-cancer chemotherapy and diagnosis, especially those induced by the use of substituted pyridine carboxamides of formula I. Combinations containing compounds of formula I and the vitamin PP compounds and compounds with anti-pellagra activity are provided for these chemotherapies and diagnoses.
Patent DE-69932227-T2 (DE)
Inventor: YOSHIMI MASASHI
IPC: H01L31/04
Filed: 1999-09-03
Granted: 2007-06-06
Abstract: At least one of a p type semiconductor layer (111), an i type amorphous silicon-based photoelectric conversion layer (112), and an n type semiconductor layer (113) that compose an amorphous silicon-based thin film photoelectric conversion device is deposited under the following conditions. Silane-type gas as a main component of raw material gas which is supplied into a reaction chamber and dilution gas containing hydrogen are used, the flow rate of the dilution gas is four or less times that of the silane-type gas, the partial pressure of the silane-type gas in the plasma CVD reaction chamber ranges from 1.2 Torr to 5.0 Torr, and the distance between a surface of a substrate mounted on an anode electrode and a surface of a cathode electrode ranges from 8 mm to 15 mm. Accordingly, a method of manufacturing an amorphous silicon-based thin film photoelectric conversion device having a superior performance is obtained with an improved efficiency in the use of raw material gas as well as an enhanced deposition rate to achieve improvements in cost and efficiency in production. Even if the dilution gas is not used, the advantages above can be achieved under the same conditions as those described above except for the condition concerning dilution gas. <IMAGE>
Patent DE-69933056-T2 (DE)
Inventor: FENDIS GREGORY
IPC: G08B25/08
Filed: 1999-12-21
Granted: 2007-04-12
Abstract: A method and system for of monitoring a site, the method including: monitoring the site for the occurrence of predetermined alarm condition; responding to the alarm condition by capturing a packet of alarm data; and transmitting the packet of alarm data to a remote location or to a communications network for transmission to the remote location.
Patent HU-E034696-T2 (HU)
Title: Treatment of talc in a solvent
Inventor: GANE PATRICK A C
IPC: C09D7/61
Filed: 2008-05-27
Abstract: The present invention is directed to a process for the treatment of tale, comprising the steps of (a) providing a tale having a first brightness value B1, measured according to ISO 2469, and forming a suspension of the talc in a liquid phase, the liquid phase of the suspension comprising at least one organic solvent, (b) delaminating and/or reducing the weight median particle size d 50  of the talc, wherein the treated talc has a brightness value B2, measured according to ISO 2469, and B2 ‰¥ B1.
Patent HU-E026926-T2 (HU)
Title: Fungicidal pyrazoles
Inventor: LONG JEFFREY KEITH
IPC: A01N25/00
Filed: 2010-03-03
Abstract: Disclosed are compounds of Formula 1, including all geometric and stereoisomers,  N -oxides, and salts thereof,
   
wherein 
Q 1   
is a phenyl ring, naphthalenyl ring system, a 5- to 6-membered fully unsaturated heterocyclic ring or an 8- to 10-membered heteroaromatic bicyclic ring system, each as described with optional substituents as defined in the disclosure; 
Q 2   
is a phenyl ring, a naphthalenyl ring system, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated heterocyclic ring, or an 8- to 10-membered heteroaromatic bicyclic ring system, each as described with optional substituents as defined in the disclosure; 
X 
is CR 15 R 16 , C(=O) or C(=S);   
and R 1 , R 1a , R 2 , R 4 , R 15 , R 16  and m are as defined in the disclosure. 
     Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.
Patent HU-E028557-T2 (HU)
Title: Tobacco dosing system
Inventor: DEKKERS RONALD PETRUS GERHARDUS
IPC: A24C1/02
Filed: 2012-05-14
Abstract: A tobacco dosing system (1) for providing doses of tobacco (4), wherein the dosing system (1) comprises a tobacco supply (3) constructed and arranged to supply tobacco (4), a dosing device (5) comprising at least one dosing cup (11, 12) for receiving the tobacco (4) to be dosed, a gas flow device (6) constructed and arranged to in use provide a gas flow (10) through the tobacco received by the at least one dosing cup (11, 12), a gas flow measuring (7) device constructed and arranged to measure a property of the gas flow (10), and a controlling device (8) operably connected to the dosing device (5) and the gas flow measuring device (7) to control the operation of the tobacco dosing system (1) on basis of the measured property.
Patent HU-E033582-T2 (HU)
Title: Purification of cell culture derived alpha1 protease inhibitor
Inventor: OWNBY DAVID
IPC: C07K14/81
Filed: 2013-07-10
Abstract: Described herein are methods for purifying recombinant, cell culture derived alpha 1 -protease inhibitor and removing a colored species that co-purifies with the recA1PI protein. Also described are methods for reducing the iron in cell culture derived alpha 1 -protease inhibitor.
Patent TR-200002019-T2 (TR)
Title: 1,3,4-Okzadiazolon türevleri.
Inventor: HEWAWASAM PIYASENA
IPC: A61P43/00
Filed: 1999-01-15
Abstract: Mevcut bulus; yüksek ölçüde iletkenlige sahip kalsiyum-aktivasyonlu potasyum kanallarinin açilmasinin sorumlulugundaki rahatsizliklarin tedavisinde faydali olan, içerisinde A,B,D ve R' nin yukarida tanimlandigi gibi oldugu genel formüle        Formül (I)        sahip, yeni okzadiazolon türevlerini veya bunlarin toksik olmayan, farmasötik olarak kabul edilebilen bir tuzu veya solvatini saglamaktadir.
Patent TR-200002455-T2 (TR)
Title: Dahili bir yanmalı motorda teklemeyi ortaya çıkarma yöntemi ve söz konusu yöntemi yerine getirmek için bir sistem.
Inventor: CECCARANI MASSIMO
IPC: G01M15/00
Filed: 1998-08-17
Abstract: Asagidakileri içeren dahili bir yanmali motorun silindirlerinden 3, 3' bir veya daha fazlasindaki bir teklemeyi ortaya çikarma yöntemi:        - örnekleme sikligi krank mili dönme hizina orantili olmak üzere en az bir motor devri sirasinda egzoz gazi basinç degerlerini örnekleme;        - siklik alaninda örneklenen sinyali analiz etme;        - söz konusu analizin sonuçlarinin bir fonksiyonu olarak bir tekleme endeksini hesaplama;        - söz konusu endeksi baslangiç degerlerinden biri veya daha fazlasi ile karsilastirma. Söz konusu siklik alani analizi, örneklenen sinyalin bir Fourier dönüsümünü içerir. Mevcut bulus, söz konusu yöntemi yerine getirme sistemi ile de ilgilidir.
Patent TR-200003377-T2 (TR)
Title: Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol
Inventor: PICKAR JAMES HARRISON
IPC: A61K31/565
Filed: 1999-05-11
Abstract: Bu bulus, bir veya daha fazla estrojen ve 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol bilesiklerini içeren, estrojenik ajanlar olarak yararli yeni formülasyonlar ve farmakolojik kompozisyonlar ile bilesikleri kullanan tedavi yöntemlerine iliskin olup burada (I) ve (II) genel yapilari söz konusudur.
Patent TR-200100684-T2 (TR)
Title: Kayar yaylardan oluşan katlanabilir üst bölüm
Inventor: FLIEGE DIETER
IPC: B60J7/06
Filed: 1999-09-01
Abstract: Bu bulusun  amaci, katlanabilir üst yapi açik oldugunda yükleme platformunun yeterli derecede açilmasi ile birbirlerine dogru itilmis olan kayar yaylar arasindaki tentenin kontrollü olarak katlanabilmesine izin veren, kayar yaylardan olusan katlanabilir üst yapi sunmaktir.
Patent TR-200102448-T2 (TR)
Title: COPD tedavisi için kontrollu salma formülasyonu.
Inventor: FAULKNER PATRICK G
IPC: A61K9/22
Filed: 2000-02-22
Abstract: Bu bulus, astim veya COPD veya benzeri gibi bir enflamatuar hastaligin tedavisinde bir PDE4 inhibitörü iletmek üzere tasarlanmis bir kontrollü veya gecikmeli salma formülasyonu ile ilgilidir.
Patent DE-602004004493-T2 (DE)
Inventor: VERMONET CLAIRE
IPC: F02D41/24
Filed: 2004-11-18
Granted: 2007-11-08
Abstract: The system has a unit (66) modifying values of conditioning parameters in a pressure acquisition chain (28) according to values of the conditioning parameters that are determined by an information processing unit (34). A determination unit (62) calculates offset value (P offset) with respect to reference pressure values (P 0) and values of signals delivered by a cylinder pressure sensor (30).
Patent DE-602004005484-T2 (DE)
Inventor: MIESEL KEITH A
IPC: A61N1/36
Filed: 2004-10-01
Granted: 2007-11-29
Abstract: A method and an apparatus are provided for interacting with targeted tissue of a patient. The apparatus comprises a central control module, a satellite module, and a lead. The satellite module comprises a processor, a communication module, a switching module, a memory, a sense amp, and a A/D converter. The apparatus is adapted for subcutaneous implantation. The central control module is coupled to the satellite module. The lead is coupled to the satellite module. A programming word comprising information to be sent to the satellite module is provided. The programming word is converted into identifiable groups of pulses corresponding to bits of the programming word. The identifiable groups of pulses are sent to the satellite module. The identifiable groups of pulses are converted to information for providing a therapy to the patient. The energy from the identifiable groups of pulses is stored to power the satellite module.
Patent DE-602004005585-T2 (DE)
Inventor: GREAVES ANDREW
IPC: A61Q5/08
Filed: 2004-04-01
Granted: 2007-12-06
Abstract: Method for dyeing human keratin materials to impart a brightening effect by application of at least one fluorescent bis(1-pyridinium-2-aminophenyl-ethene) dye (I). Method for dyeing human keratin materials to impart a brightening effect by application of at least one fluorescent bis(1-pyridinium-2-aminophenyl-ethene) dye of formula (I). [Image] R 1and R 2H, a substituent or together complete a ring; R 3and R 4H or 1-4C alkyl; each R 5H, halo, or 1-4C alkyl, optionally interrupted by at least one heteroatom; each R 6H, halo, or 1-4C alkyl, optionally substituted and/or interrupted by at least one heteroatom and/or a group that contains at least one heteroatom and/or substituted by at least one halo; X : 1-14C alkyl or 2-14C alkenyl (optionally substituted and/or interrupted by at least one heteroatom and/or a group that contains at least one heteroatom and/or substituted by at least one halo), 5-6 membered heterocycle (optionally substituted by at least one 1-14C alkyl or 1-4C aminoalkyl (both optionally substituted by at least one heteroatom) or at least one halo), aromatic or diaromatic (fused or not, optionally separated by 1-4C alkyl) group (optionally substituted by one or more halo or 1-10C alkyl (optionally substituted and/or interrupted by at least one heteroatom and/or a group that contains at least one heteroatom)), or dicarbonyl, and X may contain one or more positive charges; a : 0 or 1; each Y : organic or inorganic anion; n : integer at least 2 and at most equal to the number of positive charges in the dye molecule The full definitions are given in the DEFINITIONS (Full Definitions) Field. Independent claims are also included for the following: (1) compositions containing the new (I); and (2) multicomponent device containing (a) a composition of (2), optionally also a direct dye, oxidation base and/or coupler and (b) an oxidant.